MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 66 filers reported holding MERSANA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $119,000 | -35.3% | 29,837 | +0.8% | 0.00% | – |
Q4 2021 | $184,000 | -42.0% | 29,586 | -11.9% | 0.00% | – |
Q3 2021 | $317,000 | -35.2% | 33,572 | -6.7% | 0.00% | – |
Q2 2021 | $489,000 | -24.1% | 35,986 | -9.6% | 0.00% | – |
Q1 2021 | $644,000 | +5.9% | 39,801 | +74.2% | 0.00% | – |
Q4 2020 | $608,000 | +64.3% | 22,850 | +15.1% | 0.00% | – |
Q3 2020 | $370,000 | -20.6% | 19,860 | -0.3% | 0.00% | – |
Q2 2020 | $466,000 | +448.2% | 19,915 | +36.3% | 0.00% | – |
Q1 2020 | $85,000 | +11.8% | 14,611 | +9.5% | 0.00% | – |
Q4 2019 | $76,000 | -17.4% | 13,348 | -77.1% | 0.00% | – |
Q3 2019 | $92,000 | -81.5% | 58,237 | -52.6% | 0.00% | – |
Q2 2019 | $498,000 | -19.4% | 122,873 | +4.6% | 0.00% | -100.0% |
Q1 2019 | $618,000 | +30.9% | 117,514 | +1.7% | 0.00% | – |
Q4 2018 | $472,000 | -26.9% | 115,574 | +78.8% | 0.00% | -100.0% |
Q3 2018 | $646,000 | -17.9% | 64,626 | +46.6% | 0.00% | 0.0% |
Q2 2018 | $787,000 | +42.6% | 44,088 | +26.0% | 0.00% | 0.0% |
Q1 2018 | $552,000 | +42.6% | 34,984 | +48.5% | 0.00% | – |
Q4 2017 | $387,000 | -4.9% | 23,555 | +0.2% | 0.00% | – |
Q3 2017 | $407,000 | – | 23,516 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 8,663,673 | $40,026,000 | 4.69% |
Opaleye Management Inc. | 1,047,000 | $4,837,000 | 2.18% |
Sarissa Capital Management LP | 4,299,297 | $19,863,000 | 2.00% |
Decheng Capital Management III (Cayman), LLC | 904,268 | $4,178,000 | 1.58% |
SILVERARC CAPITAL MANAGEMENT, LLC | 850,000 | $3,927,000 | 1.21% |
Orbimed Advisors | 9,011,437 | $41,633,000 | 0.75% |
Avoro Capital Advisors LLC | 7,550,000 | $34,881,000 | 0.69% |
Rock Springs Capital Management LP | 4,075,958 | $18,831,000 | 0.55% |
Artal Group S.A. | 2,200,000 | $10,164,000 | 0.54% |
DAFNA Capital Management LLC | 406,763 | $1,879,000 | 0.51% |